Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

QUIC-CONCEPT

Financiado

QUantitative Imaging in Cancer: CONnecting CEllular Processes with Therapy

The QuIC-ConCePT consortium has 2 objectives: 1.(90% of resource, WP2-5) to qualify 3 specific imaging biomarkers (IBs) of tumour cell proliferation, apoptosis, and necrosis, to allow drug developers to demonstrate reliably modula... ver más

30/06/2018

EORTC

16M€

Presupuesto del proyecto: 16M€

Líder del proyecto

EUROPEAN ORGANISATION FOR RESEARCH AND TREATM... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 21 Participantes

Financiación concedida El organismo FP6 notifico la concesión del proyecto el día 2018-06-30 No tenemos la información de la convocatoria

0% 100%

21 Participantes

EORTC

Lider

N.D. | Participante

Pfizer RD UK Limited

N.D. | Participante

CR-UK

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

METABOLIGHT Optical imaging platform to unravel metabolic reprogramming... 2M€ Cerrado

SAF2011-23870 MEJORA DE LOS PROTOCOLOS PARA DIAGNOSTICO Y SEGUIMIENTO DE R... 327K€ Cerrado

CTQ2017-85658-R TG-DIAG: NUEVAS ESTRATEGIAS DE DIAGNOSTICO BASADAS EN FLUORE... 116K€ Cerrado

TIN2013-43457-R CARACTERIZACION DE FIRMAS BIOLOGICAS DE GLIOBLASTOMAS MEDIAN... 80K€ Cerrado

CTQ2014-56370-R UNA PLATAFORMA DE MULTI-IMAGEN PARA LA EVALUACION DEL METABO... 120K€ Cerrado

EQC2021-007743-P Implementación de plataforma de microscopía automatizada par... 607K€ Cerrado

Duración del proyecto: 81 meses Fecha Inicio: 2011-09-01
Fecha Fin: 2018-06-30

Líder del proyecto

EUROPEAN ORGANISATION FOR RESEARCH AND TREATM... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 16M€

Descripción del proyecto The QuIC-ConCePT consortium has 2 objectives: 1.(90% of resource, WP2-5) to qualify 3 specific imaging biomarkers (IBs) of tumour cell proliferation, apoptosis, and necrosis, to allow drug developers to demonstrate reliably modulation of these pathologic processes in tumours in patients in realistic trials. Our vision for January 2016 is that drug developers can incorporate these IBs for decision-making in Phase I trials of investigational therapies, confident that the IBs are technically valid, that a measured change in the IB faithfully reflects the desired change in the underlying tumour pathology, and that the IBs can be readily deployed in multiple cancer centres in a robust, consistent, ethical, and cost-effective way acceptable to patients.2.(10% of resource, WP6) includes a portfolio of innovative approaches to devise, evaluate and introduce IBs of invasion and metastasis.The IBs of tumour cell proliferation and necrosis will be developed respectively from FLT PET and ADC MRI respectively. Initial apoptosis plans focus on ICMT11 PET, possibly with other IBs introduced later. The project will be delivered using a portfolio of animal (WP2), human (WP3), image analysis (WP4) and regulatory (WP5) work. The project will be coordinated and the interdependent workpackages integrated in WP1. These WPs will deliver image acquisition and analysis protocols which are technically valid, standardised and suitable for multicentre use. We will evaluate reproducibility, effects of intervention, timing, dose-response, and imaging-histopathology correlation in animals and patients. The project is timely, and highly likely to deliver IBs which will markedly improve drug development, and benefit cancer patients in Europe and globally. The managing entity (EORTC) is already world-leading in the qualification of IBs, and the consortium includes in the academic and EFPIA partners some of the worlds most productive and innovative physicians and scientists in cancer imaging.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores